Hyperlipidemia refers to abnormal elevation of lipids and/or lipoprotein levels. Risk factors associated with such condition include stroke, peripheral vascular disease, atherosclerosis, diabetes, obesity, hypertension and other cardiovascular diseases. Drugs which are used to treat hyperlipidemia act by either accelerating the elimination of lipoproteins from the body or decrease production of lipoproteins. These medications not only lower the unwanted cholesterol levels but also prove to be vital for lowering the risk of heart attacks or strokes.
The global hyperlipidemic prescription drugs market is categorized based on drug classes namely:
- HMG COA reductase inhibitors
- Fibric acid derivatives
- Nicotinic acid
- Bile acid sequestrating agents
- Cholesterol absorption inhibitors
- Combination drug therapy
North America currently dominates the global hyperlipidemia prescription drugs market and is followed by Europe due to high prevalence of diseases associated with elevated levels of lipoproteins and the growing baby boomer population. Emerging economies of Asia-Pacific, Latin America and Middle East are also expected to undergo rapid market growth for hyperlipidemic drugs.
One of the major factors driving the global hyperlipidemic prescription drugs market is increasing susceptibility to heart diseases associated with aging population. Other factors such as patent expiration and the consequent genericization in the market, availability of funding and undertaking of health awareness programs by healthcare centers, high incidence rates of cardiovascular diseases and rising awareness among people for reducing the harmful cholesterol levels to control heart diseases. A large number of hyperlipidemia drugs are in phase III of clinical trials for their assessment in providing clinical benefits and long-term safety records.
Some of the key players contributing to hyperlipidemia prescription drugs market include Amgen, Inc., Eli Lilly and Company, GlaxoSmithKline Pharmaceuticals Limited, Isis Pharmaceuticals, Inc., Merck & Co., Inc., Dr. Reddy's Laboratories Limited, Immuron Limited, Esperion Therapeutics, Inc., Pfizer, Inc. and Formac Pharmaceuticals N.V.
This research report analyzes this market depending on its market segments, major geographies, and current market trends. Geographies analyzed under this research report include
- North America
- Asia Pacific
- Europe
- Rest of the World
This report provides comprehensive analysis of
- Market growth drivers
- Factors limiting market growth
- Current market trends
- Market structure
- Market projections for upcoming years
This report is a complete study of current trends in the market, industry growth drivers, and restraints. It provides market projections for the coming years. It includes analysis of recent developments in technology, Porter’s five force model analysis and detailed profiles of top industry players. The report also includes a review of micro and macro factors essential for the existing market players and new entrants along with detailed value chain analysis.
Browse Upcoming Reports @:http://www.transparencymarketresearch.com/pharmaceutical-market-reports-1.html
About us:-
Transparency Market Research (TMR) is a market intelligence company providing global business research reports and consulting services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insights for thousands of decision-makers.
TMR’s experienced team of analysts, researchers, and consultants use proprietary data sources along with various tools and techniques to gather and analyze information. Our business offerings represent the latest and the most reliable information which is indispensable for businesses to sustain their competitive edge.
Our data repository is continuously updated and revised by a team of research experts so that it always reflects the latest trends and information. With broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.
Contact us:-
State Tower,
90 State Street,
Suite 700,
Albany NY - 12207
United States
Tel: +1-518-618-1030
No comments:
Post a Comment